Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome

计划入组 12 人 · 首次发布于 2016 年 10 月 28 日

Clinical Evaluation and Assesment of Ginigivitis Patients Treated by Yarrow Natural Extract in Compare to a Contro Group

计划入组 40 人 · 首次发布于 2023 年 10 月 6 日

Use of J3 Bioscience Lubricating Intravaginal Ring VR101 to Relieve the Symptoms of Vaginal Dryness

计划入组 72 人 · 首次发布于 2017 年 5 月 12 日

Epoetin alfa biosimilar (Siam Bioscience)

NIMA (Sprint Bioscience)

VADA (Sprint Bioscience)

INFLECTIS BIOSCIENCE

France

Lexaria Bioscience

United States

Aytu BioScience

United States

VYNE Therapeutics and Yarrow Bioscience Merger Nears Completion: Cash Dividend Distributed, Reverse Stock Split Set, and YB-101 Poised to Advance Autoimmune Thyroid Disease Pipeline

GenSci Partners with RTW Investments in $1.365 Billion Deal for First-in-Class Thyroid Autoimmune Disease Therapy

Skye Bioscience Advances Nimacimab into Phase 2 Obesity Trial